跳至主要内容
临床试验/ISRCTN14373079
ISRCTN14373079已完成4 期

A study to survey the oral health status of Canadian seniors and to prevent poor oral health in Canadian seniors

CHX Technologies Inc0 个研究点目标入组 151 人开始时间: 2023年8月18日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
151

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Older adults (65 years of age and over at screening)
  • 2. Residents of the Greater Ottawa community and Bruyère independent living, assisted living and longterm care
  • 1. Matches the criteria of Phase A
  • 2. Clears the dental screening performed in Phase A:
  • 2.1. Bleeding on probing at = 12 sites at Screening
  • 2.2. Minimum of 15 natural teeth
  • 2.3. Willing and able to provide informed consent
  • 2.4. Able to complete the study as judged by the investigators
  • 2.5. Fully vaccinated against COVID 19

排除标准

  • 1. Not 65 years of age or over
  • 2. No bleeding on probing at 12 or more sites at Screening
  • 3. Not having 15 natural teeth or more
  • 4. Active caries which, in the judgement of the investigators, could require major surgical restoration and referral to a dentist. Those that can be readily managed by the examining hygienist (for example, small caries only requiring a temporary filling or silver diamine fluoride) will still be included in Part B.
  • 5. Severe periodontal disease which, in the judgement of the investigators, could require surgery or a level of periodontal scaling such that participation in the study will be delayed
  • 6. Undergoing periodontal care by a dentist or hygienist which in the judgement of the investigators could confound the study results.
  • 7. Known allergies to the ingredients of the study medications (chlorhexidine, Sumatra benzoin, ethanol and polymethylmethacrylate)
  • 8. Taking anti-inflammatory medication (excluding baby aspirin, prednisone or NSAIDS) or medications for periodontal conditions (e.g. Periostat, chlorhexidine rinse, PerioChip or Arestin).
  • 9. At Screening, taking antibiotics for oral abscesses, oral pain or taking antibiotics for more than 14 days
  • 10. Uncontrolled epilepsy
  • 11. A gag reflex
  • 12. Cancer that is in an active stage or has been treated with chemotherapy and/or radiation in the past year or in the next 12 months
  • 13. Severe bleeding disorders (given the need to conduct debridement in this study)
  • 14. Behavioral disorders which in the judgement of the investigators threaten the patient’s tolerance to treatment and participation in the study
  • 15. Involved in another drug trial
  • 16. Unwilling or unable to provide informed consent including consent by the Substitute decision maker
  • 17. An evident inability to complete the study as judged by the investigators
  • 18. Not fully vaccinated against COVID 19

研究者

发起方
CHX Technologies Inc

相似试验

A study to survey the oral health status of Canadian... | 临床试验